Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (60)
2025 (847)
2024 (934)
2023 (918)
2022 (1034)
2021 (1042)
2020 (875)
2019 (789)
2018 (914)
2017 (936)
2016 (881)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (11754)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Rinne SS
JSON
CSV
XLSX
TXT
Family name
Rinne
Given name
Sara S
Initials
SS
ORCID
ORCID
0000-0003-2141-3982
Affiliations
Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden.
10 publications
PubMed
DOI
Crossref
Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors.
Chernov V, Rybina A, Zelchan R, ...,
Tolmachev V
,
Orlova A
Cancers (Basel)
15
(6) - [2023-03-07; online 2023-03-07]
PubMed
DOI
Crossref
Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model.
Xu T
,
Schulga A
, Konovalova E, ...,
Tolmachev V
,
Vorobyeva A
Int J Mol Sci
24
(3) - [2023-02-02; online 2023-02-02]
PubMed
DOI
Crossref
Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [68Ga]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation.
Lundmark F
, Abouzayed A,
Rinne SS
, ...,
Rosenström U
,
Orlova A
Cancers (Basel)
15
(2) - [2023-01-10; online 2023-01-10]
PubMed
DOI
Crossref
Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules.
Rinne SS
, Yin W, Borras AM, ...,
Orlova A
,
Gräslund T
Biomedicines
10
(6) - [2022-05-31; online 2022-05-31]
PubMed
DOI
Crossref
Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands.
Lundmark F
, Olanders G,
Rinne SS
, ...,
Orlova A
,
Rosenström U
Pharmaceutics
14
(5) - [2022-05-20; online 2022-05-20]
PubMed
DOI
Crossref
HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers.
Rinne SS
, Leitao CD, Abouzayed A, ...,
Löfblom J
,
Orlova A
Cancers (Basel)
13
(19) - [2021-09-24; online 2021-09-24]
PubMed
DOI
Crossref
Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1.
Deyev SM
,
Xu T
,
Liu Y
, ...,
Tolmachev V
,
Vorobyeva A
Cancers (Basel)
13
(14) - [2021-07-17; online 2021-07-17]
PubMed
DOI
Crossref
PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology.
Rinne SS
,
Orlova A
,
Tolmachev V
Int J Mol Sci
22
(7) - [2021-04-01; online 2021-04-01]
PubMed
DOI
Crossref
Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer.
Baun C
, Mitran B,
Rinne SS
, ...,
Orlova A
,
Thisgaard H
Molecules
25
(24) - [2020-12-18; online 2020-12-18]
PubMed
DOI
Crossref
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer.
Abouzayed A, Tano H,
Nagy Á
, ...,
Eriksson Karlström A
,
Orlova A
Pharmaceutics
12
(10) - [2020-10-16; online 2020-10-16]
SciLifeLab Data Centre
Publications
9.5.1